Alza Hit With Class Action Lawsuit Over Ditropan XL
Johnson & Johnson subsidiary Alza Corporation has been smacked with a class-action antitrust lawsuit, accusing the unit of illegally trying to keep generic versions of overactive bladder drug Ditropan XL off...To view the full article, register now.
Already a subscriber? Click here to view full article